Efficacy and safety of house dust mite sublingual immunotherapy in preschool children with allergic rhinitis
Not Applicable
Completed
- Conditions
- Perennial allergic rhinitis
- Registration Number
- JPRN-UMIN000039939
- Lead Sponsor
- ational Sagamihara Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have received immunotherapy. 2) Uncontrolled asthma patients. 3) Patients who were judged to be unsuitable for patient enrollment by their doctor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement rate of nasal and eye symptom scores after a year
- Secondary Outcome Measures
Name Time Method Improvement rate of Medication scores after a year Frequency of adverse reaction Change of parameters in blood Sensitization of other inhaled antigens